X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15049) 15049
percutaneous coronary intervention (10938) 10938
male (10357) 10357
female (9807) 9807
cardiac & cardiovascular systems (9658) 9658
middle aged (8473) 8473
aged (8462) 8462
treatment outcome (7698) 7698
risk factors (5441) 5441
percutaneous coronary intervention - adverse effects (4707) 4707
time factors (4408) 4408
stents (3541) 3541
mortality (3338) 3338
transluminal angioplasty (3008) 3008
angioplasty (2946) 2946
cardiovascular (2859) 2859
coronary angiography (2851) 2851
cardiology (2756) 2756
retrospective studies (2630) 2630
drug-eluting stents (2607) 2607
prospective studies (2421) 2421
cardiac patients (2334) 2334
heart attacks (2334) 2334
risk assessment (2258) 2258
aged, 80 and over (2236) 2236
care and treatment (2154) 2154
coronary artery disease - therapy (2131) 2131
myocardial infarction (2108) 2108
outcomes (2073) 2073
abridged index medicus (2041) 2041
percutaneous coronary intervention - methods (1997) 1997
follow-up studies (1956) 1956
myocardial infarction - therapy (1859) 1859
thrombosis (1854) 1854
percutaneous coronary intervention - instrumentation (1831) 1831
coronary heart disease (1819) 1819
stent (1819) 1819
analysis (1805) 1805
clopidogrel (1750) 1750
intervention (1749) 1749
percutaneous coronary intervention - mortality (1632) 1632
platelet aggregation inhibitors - therapeutic use (1628) 1628
registries (1599) 1599
cardiovascular disease (1589) 1589
peripheral vascular disease (1576) 1576
patients (1568) 1568
angioplasty, balloon, coronary - adverse effects (1562) 1562
surgery (1561) 1561
coronary artery disease (1555) 1555
heart attack (1534) 1534
adult (1527) 1527
predictive value of tests (1484) 1484
acute myocardial-infarction (1475) 1475
prognosis (1470) 1470
prosthesis design (1452) 1452
risk (1430) 1430
impact (1358) 1358
myocardial-infarction (1349) 1349
coronary vessels (1342) 1342
implantation (1340) 1340
medicine & public health (1329) 1329
ticlopidine - analogs & derivatives (1323) 1323
myocardial infarction - mortality (1316) 1316
angiography (1280) 1280
kaplan-meier estimate (1244) 1244
artery-disease (1232) 1232
incidence (1220) 1220
platelet aggregation inhibitors - adverse effects (1213) 1213
cardiovascular diseases (1170) 1170
acute coronary syndromes (1161) 1161
coronary artery disease - surgery (1158) 1158
revascularization (1149) 1149
myocardial infarction - etiology (1147) 1147
cardiology and cardiovascular medicine (1138) 1138
medicine, general & internal (1137) 1137
multivariate analysis (1130) 1130
coronary artery disease - mortality (1124) 1124
electrocardiography (1100) 1100
platelet aggregation inhibitors - administration & dosage (1098) 1098
trial (1094) 1094
health aspects (1040) 1040
aspirin (1039) 1039
disease (1036) 1036
patient outcomes (1027) 1027
chi-square distribution (1022) 1022
coronary artery disease - diagnostic imaging (1018) 1018
therapy (1016) 1016
management (1007) 1007
proportional hazards models (999) 999
metaanalysis (989) 989
acute coronary syndrome (967) 967
coronary artery bypass (961) 961
odds ratio (947) 947
clinical-outcomes (935) 935
heart (924) 924
usage (915) 915
logistic models (905) 905
elevation myocardial-infarction (877) 877
research (874) 874
myocardial infarction - diagnosis (868) 868
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17440) 17440
Japanese (96) 96
German (68) 68
Russian (53) 53
Spanish (53) 53
Chinese (48) 48
Portuguese (40) 40
French (24) 24
Polish (19) 19
Italian (16) 16
Dutch (12) 12
Turkish (11) 11
Korean (4) 4
Norwegian (4) 4
Hebrew (2) 2
Hungarian (2) 2
Serbian (2) 2
Swedish (2) 2
Arabic (1) 1
Danish (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2019, Volume 321, Issue 24, pp. 2428 - 2437
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
... (DES) recipients is 12 months to reduce the risk of late stent thrombosis, particularly in those with acute coronary syndrome (ACS... 
double antiplatelet duration | percutaneous coronary angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | THROMBOSIS | BARE-METAL STENTS | FOLLOW-UP | RISK | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | POOLED ANALYSIS | CLINICAL-OUTCOMES | PLATELET REACTIVITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2015, Volume 66, Issue 9, pp. 1036 - 1045
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2013, Volume 62, Issue 11, pp. 981 - 989
...) patients after myocardial infarction (MI) or percutaneous coronary intervention (PCI). Background The optimal antithrombotic treatment strategy is unresolved in patients with multiple indications... 
Cardiovascular | Internal Medicine | atrial fibrillation | bleeding | stroke | myocardial infarction | antithrombotic treatment | NORTH-AMERICAN PERSPECTIVE | CARDIAC & CARDIOVASCULAR SYSTEMS | SYNDROME AND/OR | RE-LY TRIAL | LONG-TERM ANTICOAGULATION | NATIONWIDE COHORT | EUROPEAN-SOCIETY | CONSENSUS DOCUMENT | WORKING GROUP | ANTITHROMBOTIC THERAPY | TRIPLE THERAPY | Myocardial Infarction - epidemiology | Ticlopidine - therapeutic use | Humans | Male | Incidence | Aspirin - adverse effects | Ticlopidine - adverse effects | Aged, 80 and over | Female | Registries | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Postoperative Complications | Platelet Aggregation Inhibitors - adverse effects | Administration, Oral | Atrial Fibrillation - therapy | Risk Factors | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Denmark - epidemiology | Aged | Myocardial Infarction - prevention & control | Percutaneous Coronary Intervention | Sects | Anticoagulants (Medicine) | Atrial fibrillation | Cardiac patients | Heart attack | Anticoagulants | Stroke | Heart attacks | Drug therapy
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 01/2015, Volume 8, Issue 1, pp. 214 - 220
... (European Ambulance Acute Coronary Syndrome Angiography) trial. BACKGROUND: Bivalirudin started during transport for primary percutaneous coronary intervention (PCI... 
Bivalirudin | Percutaneous coronary intervention | ST-segment elevation myocardial infarction | Stent thrombosis | CARDIAC & CARDIOVASCULAR SYSTEMS | bivalirudin | MANAGEMENT | TICAGRELOR | BARE-METAL | SOCIETY | percutaneous coronary intervention | CLOPIDOGREL | THERAPY | stent thrombosis | ACUTE MYOCARDIAL-INFARCTION | POSITION PAPER | ASSOCIATION | Multivariate Analysis | Predictive Value of Tests | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Myocardial Infarction - diagnostic imaging | Recombinant Proteins - adverse effects | Hirudins - administration & dosage | Coronary Thrombosis - diagnostic imaging | Myocardial Infarction - therapy | Percutaneous Coronary Intervention - instrumentation | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Coronary Thrombosis - prevention & control | Female | Odds Ratio | Stents | Drug Administration Schedule | Europe | Peptide Fragments - administration & dosage | Risk Factors | Logistic Models | Treatment Outcome | Anticoagulants - adverse effects | Chi-Square Distribution | Recombinant Proteins - administration & dosage | Coronary Angiography | Hirudins - adverse effects | Aged | Coronary Thrombosis - etiology | Peptide Fragments - adverse effects | Ambulances | Percutaneous Coronary Intervention - adverse effects
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 10/2016, Volume 88, Issue 4, pp. 535 - 544
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2465 - 2476
Journal Article
JACC. Cardiovascular interventions, ISSN 1936-8798, 01/2014, Volume 7, Issue 11, pp. 1287 - 1293
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 10, pp. 961 - 972
In this large randomized trial (SYNTAX), patients with three-vessel or left main coronary artery disease were randomly assigned to undergo revascularization by means of either percutaneous coronary intervention (PCI... 
coronary artery disease | major clinical study | heart infarction | angiotensin receptor antagonist | warfarin derivative | hydroxymethylglutaryl coenzyme A reductase inhibitor | percutaneous coronary intervention | female | clinical trial | in-stent restenosis | coronary artery bypass graft | classification | treatment outcome | article | cerebrovascular accident | retreatment | dipeptidyl carboxypeptidase inhibitor | drug eluting stent | anticoagulant agent | transluminal coronary angioplasty | multicenter study | adult | beta adrenergic receptor blocking agent | male | intermethod comparison | unclassified drug | comparative study | antithrombocytic agent | thienopyridine derivative | heart muscle revascularization | calcium channel blocking agent | amiodarone | controlled clinical trial | preoperative period | priority journal | disease severity | human | histamine H2 receptor antagonist | cardiovascular disease | paclitaxel | hospitalization | aged | middle aged | stroke | acetylsalicylic acid | randomized controlled trial | controlled study | prospective study | mortality | Kaplan Meier method | SURGERY | MEDICINE, GENERAL & INTERNAL | REVASCULARIZATION | STENOSIS | THROMBOSIS | 3-VESSEL | FOLLOW-UP | RISK | OUTCOMES | SYNTAX | DRUG-ELUTING STENTS | Severity of Illness Index | Coronary Artery Disease - surgery | Drug-Eluting Stents | Myocardial Infarction - mortality | Coronary Artery Disease - classification | Prospective Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Retreatment - statistics & numerical data | Treatment Outcome | Coronary Artery Disease - mortality | Angioplasty, Balloon, Coronary - adverse effects | Coronary Artery Bypass - adverse effects | Coronary Artery Disease - therapy | Cardiovascular Diseases - epidemiology | Female | Aged | Stroke - mortality | Care and treatment | Usage | Coronary artery bypass | Causes of | Diagnosis | Coronary heart disease | Health aspects | Cardiovascular disease | Postoperative period | Heart attacks | Stents | Coronary vessels
Journal Article